Daxor Operating Income 2010-2011 | DXR

Daxor operating income from 2010 to 2011. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Daxor Annual Operating Income
(Millions of US $)
2011 $-6
2010 $-6
2009 $-5
Daxor Quarterly Operating Income
(Millions of US $)
2011-12-31 $-1
2011-09-30 $-1
2011-06-30 $-1
2011-03-31 $-2
2010-12-31 $-2
2010-09-30 $-1
2010-06-30 $-2
2010-03-31 $-1
2009-12-31 $-1
2009-09-30 $-1
2009-06-30 $-1
2009-03-31 $-1
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.052B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $20.620B 19.70
Encompass Health (EHC) United States $12.443B 24.86
DaVita (DVA) United States $9.826B 14.05
Elanco Animal Health (ELAN) United States $8.674B 19.40
Chemed (CHE) United States $6.639B 22.24
RadNet (RDNT) United States $5.280B 190.67
Option Care Health (OPCH) United States $4.418B 18.90
Addus HomeCare (ADUS) United States $2.114B 22.79
LifeStance Health (LFST) United States $2.081B 0.00
U.S Physical Therapy (USPH) United States $1.279B 31.98
Pennant (PNTG) United States $0.870B 30.68
MEDIROM Healthcare Technologies (MRM) Japan $0.052B 0.00
Psychemedics (PMD) United States $0.000B 0.00